Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial

Autor: Lionel Rostaing, Suphamai Bunnapradist, Josep M. Grinyó, Kazimierz Ciechanowski, Jason E. Denny, Helio Tedesco Silva, Klemens Budde, Sanjay Kulkarni, Donald Hricik, Barbara A. Bresnahan, Rafik A. El-Sabrout, Laurence K. Chan, Gaetano Ciancio, Mohamed A. El-Ghoroury, Michael J. Goldstein, Robert S. Gaston, Reginald Y. Gohh, Mary T. Killackey, Anne King, Richard J. Knight, Arputharaj H. Kore, Debra L. Sudan, Javier Chapochnick Friedmann, Shamkant P. Mulgaonkar, Charles Nolan, Oleh G. Pankewycz, John D. Pirsch, Heidi M. Schaefer, Steven M. Steinberg, Bruce E. Gelb, Karin A. True, Patricia M. West-Thielke, Mary M. Waybill, Joshua H. Wolf, Beverley L. Ketel, Robert C. Harland, Fuad S. Shihab, Elisabeth Cassuto, Yannick Le Meur, Christophe Mariat, Josep Maria Grinyó, Jose Puig, Daniel Seron, Giuseppe Tisone, Bartosz Foroncewicz, Zbigniew Wlodarczyk, Oliver Witzke, Guillermo A. Mondragon, Eduardo Mancilla Urrea, Josefina Alberu Gomez, Rafael Reyes Acevedo, Maria del Carmen Rial, Pablo A. Novoa, Helio T. Silva, Valter D. Garcia, Deise D. Carvalho, Luciana T. Santamaria Saber, Fabiana L. Contieri, Marcos G. Bastos, Roberto C. Manfro, John Kanellis, Josette Eris, Philip O’Connell, Peter Hughes, Graeme Russ, Grant B. Pidgeon, Ian D. Dittmer, Terence Kee, Anantharaman Vathsala, Radomir Naumovic, Igor Mitic, Randhawa Parmjeet

Publikováno v: American Journal of Kidney Diseases. (4):648-659

Background1-year data from this trial showed the noninferiority of a novel once-daily extended-release tacrolimus (LCPT; Envarsus XR) to immediate-release tacrolimus (IR-Tac) twice daily after kidney transplantation.Study DesignFinal 24-month analysi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52de67cbb5744401dbcd18959497af8e